Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s Disease PRECISE-AD Six Month Interim Results Expected in ...
Smriti Mandhana, and Deepti Sharma were placed in the highest, A category. For breaking news and live news updates, like us on Facebook or follow us on Twitter and Instagram. Read more on Latest ...
today announced financial results and recent corporate highlights for the full-year ended December 31, 2024. Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief Executive Officer ...
"2024 was a transformational year for ProMIS Neurosciences as we reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Kashika Kapoor shares how Kishan Reddy's recent act highlights cultural significance of Indian films
Sri Kishan Reddy’s gesture of purchasing the first ticket highlights the cultural significance of Indian films.” A source revealed that BJP leader Kishan Reddy was impressed by the film's ...
Recent Highlights Alzheimer’s Disease Program (PMN310) ProMIS’ lead candidate, PMN310, is a humanized IgG1 antibody directed toward toxic amyloid-beta (Ab) oligomers (AβO) that are believed ...
"2024 was a transformational year for ProMIS Neurosciences as we reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate for AD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback